Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Haemophilus influenzae type B
Pneumococcal disease
NITAG documentation
SAGE documentation
2013
2007
Clear all
Type of publications
NITAG documentation
(8)
SAGE documentation
(4)
Scientific publications
(3)
Systematic reviews (SYSVAC)
(9)
Topics
Agenda & Minutes
(2)
GRADE table
(3)
Position paper
(1)
Recommendation
(6)
Available to download in languages
English (EN)
(11)
Dutch (NL)
(2)
Spanish (ES)
(1)
Regions
Americas
(3)
Europe
(3)
Western Pacific
(2)
Countries
Diseases
Haemophilus influenzae type B
(9)
Pneumococcal disease
(3)
Diphtheria
(1)
Hepatitis A
(3)
Hepatitis B
(1)
Influenza
(9)
Japanese encephalitis
(2)
Measles
(1)
Meningococcal disease
(7)
Mumps
(1)
Pertussis
(1)
Rotavirus
(2)
Tick-borne encephalitis
(1)
Varicella
(3)
Yellow fever
(1)
Vaccine topics
Target population
Publication date
2013
(10)
2007
(2)
2024
(2)
2023
(8)
2022
(6)
2021
(3)
2020
(3)
2019
(9)
2018
(13)
2017
(8)
2016
(3)
2015
(8)
2014
(6)
2012
(3)
2011
(6)
2009
(2)
2008
(4)
2006
(1)
2005
(1)
2004
(2)
2003
(3)
2002
(2)
1997
(1)
1993
(1)
1991
(1)
12 results found
2013
∙
Health Council of the Netherlands
Vaccination of infants against pneumococcal infections (3) – 27 November 2013
2013
∙
PTAC Immunisation subcommittee
2013-04 immunisation subcommittee minutes
2013
∙
WHO
Haemophilus influenzae type b (Hib) Vaccination Position Paper
2013
∙
SAGE
Hib vaccination schedules: three primary doses plus one booster dose versus two primary doses plus one booster dose
2013
∙
SAGE
Hib vaccination schedules: three primary doses versus two primary doses plus one booster dose
2013
∙
SAGE
Level of clinical protection conferred by a complete primary series of Haemophilus influenzae type b (Hib) vaccination
2013
∙
ATAGI
Clinical advice for immunisation providers regarding the use of Menitorix® in delivering catch-up vaccinations, July 2013
2013
∙
CoNaIn
CoNain (NITAG of Argentina) minutes meeting - May 28th, 2013
2013
∙
JCVI
JCVI statement on the wider use of pneumococcal conjugate vaccines in the UK
2013
∙
ACIP
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6–18 Years with Immunocompromising Conditions
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register